Epidemiology


Etiology


  • Iatrogenic
    • Vascular interventions, e.g., percutaneous coronary intervention (PCI)
    • Cardiac surgery

Pathophysiology


Atherosclerosis → rupture of atherosclerotic plaque (most commonly from the aorta) → blockage and inflammation of small to medium arteries by cholesterol crystals → formation of multiple small peripheral, muscular, or visceral emboli → end-organ damage

Clinical features


  • Features of renal damage
  • Peripheral skin manifestations
    • Livedo reticularis
    • Necrosis
    • Purpura
    • Blue toe syndrome: ischemia due to small vessel occlusion that manifests as toe discoloration (pulses typically remain palpable as large arteries are unaffected)
  • Signs of gastrointestinal involvement (e.g., intestinal ischemia or pancreatitis)
  • Signs of CNS involvement (e.g., ischemic stroke or TIA)
  • Signs of retinal involvement
    • Hollenhorst plaques on retinal exam
    • Amaurosis fugax

Diagnostics


  • Biopsy
    • Amorphous, eosinophilic material in the vessel lumen
    • Spindle-shaped spaces (cholesterol clefts), formed when the fat molecules in cholesterol emboli dissolve during sample processing

Treatment